|
ZNF346 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.217220E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.038300E-04 |
| Normal-vs-Stage2 |
5.699900E-03 |
| Normal-vs-Stage3 |
3.568400E-01 |
| Normal-vs-Stage4 |
4.153800E-01 |
| Stage1-vs-Stage2 |
8.684000E-01 |
| Stage1-vs-Stage3 |
1.422980E-01 |
| Stage1-vs-Stage4 |
1.416820E-01 |
| Stage2-vs-Stage3 |
2.095600E-01 |
| Stage2-vs-Stage4 |
1.349190E-01 |
| Stage3-vs-Stage4 |
2.883400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.143000E-03 |
| Normal-vs-AfricanAmerican |
9.601000E-03 |
| Normal-vs-Asian |
9.629400E-01 |
| Caucasian-vs-AfricanAmerican |
9.758600E-01 |
| Caucasian-vs-Asian |
3.991200E-01 |
| AfricanAmerican-vs-Asian |
3.403600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.836730E-04 |
| Normal-vs-Female |
2.811000E-01 |
| Male-vs-Female |
4.277700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.769600E-02 |
| Normal-vs-Extreme_Weight |
3.899300E-03 |
| Normal-vs-Obese |
6.098100E-02 |
| Normal-vs-Extreme_Obese |
8.502400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.337000E-01 |
| Normal_Weight-vs-Obese |
4.167200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.595200E-01 |
| Extreme_Weight-vs-Obese |
3.893200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.174200E-01 |
| Obese-vs-Extreme_Obese |
4.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.953000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.721000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.34710000002192E-06 |
| Normal-vs-Age(81-100Yrs) |
1.117840E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.928400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.514600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.391400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.809280E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.750480E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.475800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.395600E-04 |
| Normal-VS-Type2 PRCC |
9.179800E-02 |
| Normal-VS-KIRP CIMP |
1.582000E-04 |
| Normal-VS-Unclassified PRCC |
4.354400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.486400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.793500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.634800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.124410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.292800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.642100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.782600E-03 |
| Normal-vs-N1 |
7.841800E-01 |
| Normal-vs-N2 |
3.788400E-01 |
| N0-vs-N1 |
1.239580E-01 |
| N0-vs-N2 |
7.319200E-01 |
| N1-vs-N2 |
6.417800E-01 |
|
|
